Fig. 2
From: Defining type 2 asthma and patients eligible for dupilumab in Italy: a biomarker-based analysis
Methodological approach to estimate dupilumab-eligible population in Italy (illustrative)
Fig. 2 | Clinical and Molecular Allergy